Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report | Citedby Results | Case Reports in Oncology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report

Case Rep Oncol (2021) 13 (3): 1185–1190.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Immune checkpoint inhibitor-related diabetes combined with hypophysitis characterized by recurrent fatigue and Anorexia: a case report

Yao Cui
Jian Zhou
Weiying Ge

Discover Medicine (2025) 2 (1)

Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care

Anmar Al-Taie
Najat Sheta

Clinical Therapeutics (2024) 46 (1): e29.

Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors

Yasunori Fujita
Fumika Kamitani
Masaaki Yamamoto
Hidenori Fukuoka
Yushi Hirota
Nobuharu Nishiyama
Naho Goda
Yuko Okada
Yuiko Inaba
Hiroki Nakajima
Yukako Kurematsu
Keitaro Kanie
Hiroki Shichi
Shin Urai
Masaki Suzuki
Naoki Yamamoto
Hironori Bando
Genzo Iguchi
Hirotaka Suto
Yohei Funakoshi
Naomi Kiyota
Yutaka Takahashi
Wataru Ogawa

Journal of the Endocrine Society (2023) 7 (3)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus

Jia Liu
Yuequan Shi
Xiaoyan Liu
Dongming Zhang
Haoran Zhang
Minjiang Chen
Yan Xu
Jing Zhao
Wei Zhong
Mengzhao Wang

Translational Oncology (2022) 24: 101473.

PD-1 inhibitor-associated type 1 diabetes: A case report and systematic review

Cuiping Lin
Xuan Li
Yu Qiu
Zheng Chen
Jianping Liu

Frontiers in Public Health (2022) 10